These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30530229)

  • 61. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
    Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
    Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression profile analysis identifies the long non-coding RNA landscape and the potential carcinogenic functions of LINC00668 in laryngeal squamous cell carcinoma.
    Zhao L; Cao H; Chi W; Meng W; Cui W; Guo W; Wang B
    Gene; 2019 Mar; 687():47-55. PubMed ID: 30415008
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
    Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
    Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.
    Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30824562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets.
    Meseure D; Drak Alsibai K; Nicolas A; Bieche I; Morillon A
    Biomed Res Int; 2015; 2015():320214. PubMed ID: 26448935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.
    Jiao C; Song Z; Chen J; Zhong J; Cai W; Tian S; Chen S; Yi Y; Xiao Y
    Oncol Rep; 2016 Nov; 36(5):2960-2966. PubMed ID: 27667646
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differentially expressed protein-coding genes and long noncoding RNA in early-stage lung cancer.
    Li M; Qiu M; Xu Y; Mao Q; Wang J; Dong G; Xia W; Yin R; Xu L
    Tumour Biol; 2015 Dec; 36(12):9969-78. PubMed ID: 26178480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. LOC100287225, novel long intergenic non-coding RNA, misregulates in colorectal cancer.
    Kazemzadeh M; Safaralizadeh R; Feizi MA; Ravanbakhsh R; Somi MH; Hashemzadeh S
    Cancer Biomark; 2016; 16(3):499-505. PubMed ID: 27062707
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CCAT2: A novel oncogenic long non-coding RNA in human cancers.
    Xin Y; Li Z; Zheng H; Chan MTV; Ka Kei Wu W
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28244168
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long non-coding RNA HOTAIR promotes carcinogenesis and invasion of gastric adenocarcinoma.
    Lee NK; Lee JH; Park CH; Yu D; Lee YC; Cheong JH; Noh SH; Lee SK
    Biochem Biophys Res Commun; 2014 Aug; 451(2):171-8. PubMed ID: 25063030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased HAGLR expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis.
    Lu C; Ma J; Cai D
    Tumour Biol; 2017 Apr; 39(4):1010428317697574. PubMed ID: 28443464
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long non-coding RNAs in cancer drug resistance development.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
    Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
    Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PRNCR1: a long non-coding RNA with a pivotal oncogenic role in cancer.
    Bardhan A; Banerjee A; Basu K; Pal DK; Ghosh A
    Hum Genet; 2022 Jan; 141(1):15-29. PubMed ID: 34727260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SOX2OT, a novel tumor-related long non-coding RNA.
    Wang Y; Wu N; Luo X; Zhang X; Liao Q; Wang J
    Biomed Pharmacother; 2020 Mar; 123():109725. PubMed ID: 31865145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.